Euglycemic Diabetic Ketoacidosis after Discontinuing SGLT2 Inhibitor
Background. Sodium glucose cotransporter-2 (SGLT2) inhibitors have been proven to be very effective in the management of type II diabetes. These medications can cause adverse drug reactions such as genital mycotic infections. Another critical adverse drug reaction is euglycemic diabetic ketoacidosis...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2022-01-01
|
| Serija: | Case Reports in Endocrinology |
| Online dostop: | http://dx.doi.org/10.1155/2022/4101975 |
| Oznake: |
Brez oznak, prvi označite!
|